Table: SymBio Pharmaceuticals -2021 parent results

SymBio Pharmaceuticals

10/02/2022 06:30

Feb 10 (Reuters)- 
          SymBio Pharmaceuticals Limited 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended       Year ended       Year to       NEXT   
                Dec 31, 2021     Dec 31, 2020   Dec 31, 2022     YEAR     
                   LATEST          YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales             8.26             2.99           10.99                 
                (+176.4 pct)      (+5.3 pct)     (+33.1 pct)              
  Operating         1.02          loss 4.51          1.77                 
                                                 (+74.2 pct)              
  Recurring         1.00          loss 4.62          1.75                 
                                                 (+74.8 pct)              
  Net               2.03          loss 4.09          1.48                 
                                                 (-27.2 pct)              
  EPS             53.04 yen    loss 124.13 yen    38.63 yen               
  EPS Diluted     52.32 yen                                               
  Ann Div            NIL             NIL             NIL                  
  -Q2 Div            NIL             NIL             NIL                  
  -Q4 Div            NIL             NIL             NIL                  
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T